Immucor and Mohawk Medbuy Corporation Sign 10 Year

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
151
Immucor and Mohawk Medbuy Corporation Sign 10 Year Automation Agreement for CoLabs

NORCROSS, Ga., July 26, 2017 (GLOBE NEWSWIRE) -- Immucor Inc., a global leader in transfusion and transplantation diagnostics, announces a partnership with CoLabs Laboratory Medicine Network. In a unified vision for a regional transfusion lab medicine model, this partnership is designed to drive innovation through reagents, scalable automation and data management solutions. The ultimate goal is to improve the overall patient experience and optimize efficiency, quality and performance across all CoLabs sites.

Today’s immunohematology labs are faced with many challenges while continuing to ensure patient safety:  increased workloads, fewer specialized technologists, and increased demands for faster turnaround times while improving efficiency and reducing costs. The challenge has been presented to do more with less while providing the best patient service and meeting regulatory requirements. The solution to address these challenges is a LEAN workflow using Immucor’s walk away, fully automated instruments combined with its ImmuLINK® data management system.

CoLabs will implement one NEO® instrument and one Echo® instrument at each of its two high volume labs, and one Echo® instrument at each of its other 11 sites. Additionally, ImmuLINK, the centralized data management solution, will connect all Immucor instruments at the 13 sites to allow a shared model of technical and professional expertise.

Immucor shares CoLabs' vision for transfusion medicine across the region for a fully integrated, networked and sustainable system that utilizes state of the art technology and connectivity. David Langstaff, Executive Director of CoLabs states, “We are pleased to build a system together that will allow for a regional model of technical and professional expertise. By standardizing instruments and providing connectivity across all our sites, we will be bringing equal access to the latest technology for the benefits of our patients and laboratory staff across the region.”

Tony DiEmanuele, Mohawk Medbuy Corporation President and CEO states, “Our approach with hospitals is to support innovative, value-based procurement solutions. This opportunity with CoLabs demonstrates a means of supporting clinicians and providing an enhanced patient experience. This leading-edge approach helps to achieve the goal of adopting world class, state-of-the-art technology and connectivity through an integrated process with new generation equipment and savings opportunities to support lower operating costs across 13 laboratory sites.”

Dayle Tolfree, Commercial General Manager for Immucor Canada, states, “We are excited to partner with Mohawk Medbuy Corporation and CoLabs to demonstrate the value of our solution for patients, the laboratory staff and clinicians. Through standardization, centralized data management, best-in-class automation, and LEAN implementation, we are confident our solution will deliver now and for the years to come.”

Immucor’s innovative automation strategy provides scalable solutions to meet the needs of blood banks of all sizes. Immucor has continually invested in automation since 1998. The NEO, which is designed for laboratories with higher volume and/or complex testing needs, has the industry’s highest throughput. The Echo, which is designed for smaller volume laboratories, features a broad test menu, instant access and the industry’s fastest turnaround times. Both the NEO and the Echo improve transfusion medicine-related workflow productivity, safety and testing flexibility.

ImmuLINK has successfully implemented similar “hub and spoke” models across North America and Europe. Patient samples no longer have to leave a facility for additional testing. Specialized tests can be ordered and analyzed onsite with virtual review. Release and support from the reference hub sites can be completed at any time, thus improving efficiency and workflow, eliminating redundancy, and providing a standardized quality process for a cost effective solution throughout the blood bank.

Working with customers, Immucor’s team of LEAN-certified individuals incorporates LEAN Workflow Analysis throughout the implementation of its automation and on an ongoing basis to ensure that the full benefits of its solution are realized.

About CoLabs Laboratory Medicine Network CoLabs is one of the largest Laboratory Medicine Networks in Canada that works collaboratively with 8 hospital organizations in the Hamilton Niagara Haldimand Brant LHIN under a coordinated leadership model.  All hospitals are affiliated with McMaster University, Faculty of Health Sciences as an academic hospital, community teaching hospital or community placement agency. The CoLabs network performs over 12 million laboratory tests per year and is supported by approximately 1,300 employees, and 83 laboratory physicians and scientists.

About Mohawk Medbuy Corporation Mohawk Medbuy Corporation optimizes delivery of high quality and best priced medical / surgical products and pharmaceuticals through its clinical engagement, end to end supply chain, back office, and data analytics services.   Additional services include Strategic Sourcing and Contract Management, Logistics, Accounts Payable services, Linen Services, Diagnostic Imaging Repository, Employee Assistance Program (working with LifeWorks) and Capital procurement (through a formal partnership with St. Joseph’s Health System, GPO).

About Immucor Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com .

Immucor Contact: Michele Howard 770-441-2051 Mohawk Medbuy Contact: Colin Lyons 289-337-5021 CoLabs Contact: David Langstaff 905-536-8055

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Class Action: What Investors Should Know

Updated Category News Views 43

Playing Hardball: Gildan Faces Serious Claims Gildan Activewear Inc. (NYSE:GIL) isn't just dealing with wardrobe malfunctions; it's knee-deep in a class action lawsuit that's got investors on edge. The allegations? Accusations of deceptive practices like channel stuffing, which supposedly jazzed up their financials by moving unsold products through distribution channels...

Continue Reading
Blue Friday Sales: A Princess Cruises' Steal

Updated Category News Views 194

Setting Sail on Savings: Princess Cruises' Offerings When folks start talking about Black Friday, you probably think of TVs or gadgets, but Princess Cruises is flipping that idea with their 'Blue Friday' sale, running from November 6 through December 7, 2026. Now, cruises aren't your traditional doorbuster, but a vacation might just be the kind of experience worth...

Continue Reading
Andersen's Window Revamp: Addressing Demand Surge

Updated Category News Views 96

Portfolio Boost: Adapting to Market Needs If you're sniffing around the windows business, there's a fresh breeze of innovation blowing from Andersen. They're not just sitting around drumming their fingers—they're rolling up their sleeves and fine-tuning their offerings. With half of homeowners swinging a hammer on renovations last year, the company sees an opportunity...

Continue Reading
AZZ Inc.'s 2026 Sustainability Report: A Closer Look

Updated Category News Views 160

Diving into AZZ's Sustainability Commitment AZZ Inc., known in the trading circles as NYSE:AZZ, has just dropped its 2026 Sustainability Report and it’s quite the document to chew on. This ain't your typical corporate fluff. Tom Ferguson, the man steering the AZZ ship, laid it down plain and simple. This report isn’t just about ticking boxes for ESG; it’s reflecting...

Continue Reading
Lagoon Furniture Redefines Hospitality At BDNY 2026

Updated Category News Views 116

Revolutionizing Hospitality Design: A New Wave Some companies play it safe, sticking to tried-and-true approaches, but then there's Lagoon Furniture USA who's taking the bull by the horns with their fresh take on hospitality design ahead of BDNY 2026. Forget about following a set recipe; they're all about crafting unique identities for spaces! From Chairs to Sculptural...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 131

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 190

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Koppers Navigates Q3: Margins Squeeze Amid Growth

Updated Category News Views 123

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Continue Reading
F&G Boosts Dividend for Investors in Strong Signal

Updated Category News Views 251

Ring the Bell: Dividend Hike from F&G F&G Annuities & Life (NYSE: FG) just raised its dividend, and every investor worth their salt knows that means something. A 4% bump up to $0.26 per common share might not sound like a fanfare, but in the land of finance, it's an indication that this company thinks it's riding a positive wave. It’s like getting a little bonus in your...

Continue Reading
Reliving the Legacy of Friendship at Friends & Co

Updated Category News Views 152

Reconnecting With History In an era dominated by fleeting digital interactions, the heartening effort by Friends & Co stands out. This nonprofit is digging back into its roots and asking folks to share tales of the deep bonds formed over the past fifty years under its former guise, Little Brothers – Friends of the Elderly Twin Cities. The mission? To celebrate...

Continue Reading

Top 5 Most Recently Viewed Articles

Join Our Insightful Investor Webinar on Upcoming Bond Issues

Updated Category News Views 152

Exploring Opportunities in Renewable Energy Investments Atsinaujinan?ios Energetikos Investicijos is excited to extend an invitation for investors to attend an informative webinar focused on an upcoming bond issue. This event promises to provide valuable insights and information for potential investors interested in renewable energy ventures. Webinar Details You Can't...

Continue Reading
4DMedical Secures Major Funding to Expand Lung Imaging Solutions

Updated Category News Views 175

4DMedical Secures Major Funding for U.S. Expansion 4DMedical, a pioneer in software-based respiratory imaging technology, has achieved a significant milestone by securing over US$100 million in funding. This capital influx aims to exponentially accelerate the adoption of their innovative CT:VQ™ imaging product in the United States. Importance of CT:VQ™ Imaging...

Continue Reading
The Future of Anti-Counterfeit Packaging: Market Analysis

Updated Category News Views 139

Understanding the Anti-Counterfeit Packaging Market In recent years, the anti-counterfeit packaging market has been witnessing significant growth. Analysts project that it will reach an impressive USD 571.77 billion by the year 2034. Notably, the market saw a remarkable expansion from USD 148.73 billion in 2023 to around USD 165.74 billion in 2024. This trajectory implies...

Continue Reading
Ontex's Strategic Shift: Selling Brazilian Operation to Softys

Updated Category News Views 106

Ontex Group NV grabbed attention back in 2024 with its decision to sell off its Brazilian operations to Softys S. A. for a hefty BRL 671 million—around €110 million. This move wasn’t just some casual shuffle; it was a strategic play aimed at reshaping Ontex's portfolio. Why Ontex Sold: Strategic Shift or Desperation? Gustavo Calvo Paz, the CEO of Ontex, was vocal...

Continue Reading
Tesla's Cybercab Tests Bring Excitement Amid Model Y Updates

Updated Category News Views 300

Tesla Inc. Launches New Cybercab Testing Phase Tesla Inc. (NASDAQ: TSLA) is making waves in the electric vehicle sector as testing for its latest innovation, the Cybercab, unfolds at Gigafactory Texas and Fremont, California. This comes at an exciting juncture where the company has just unveiled affordable trims for its popular Model Y and Model 3. Cybercab Sighted at...

Continue Reading